Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,000,000
-
Total 13F shares
-
59,787,423
-
Share change
-
+772,839
-
Total reported value
-
$3,819,690,831
-
Put/Call ratio
-
58%
-
Price per share
-
$63.88
-
Number of holders
-
230
-
Value change
-
-$49,008,451
-
Number of buys
-
108
-
Number of sells
-
145
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q1 2022
As of 31 Mar 2022 Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) had 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 59,787,423 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, CADIAN CAPITAL MANAGEMENT, LP, JPMORGAN CHASE & CO, Casdin Capital, LLC, and ALLIANCEBERNSTEIN L.P..
This table shows 230 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.